845
Views
0
CrossRef citations to date
0
Altmetric
Retraction

Statement of Retraction: Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer

This article refers to:
RETRACTED ARTICLE: Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer

We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

Hong Gao, Xiaosong Sun, Hongdong Wang & Ying Zheng (2020) Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer, Cell Cycle, 19:10, 1186-1199, DOI: 10.1080/15384101.2020.1749466

Since publication, the authors have informed us they have not been able to replicate their results presented in this article. As this casts doubt over the results and conclusions, the authors alerted the issue to the Editor and Publisher and all have agreed to retract the article to ensure the integrity of the scholarly record.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.